Literature DB >> 11862625

Inactivation of the BSE agent.

David Taylor1.   

Abstract

In the studies carried out so far, the BSE agent has proved to be just as resistant as other TSE agents to inactivation by procedures such as autoclaving or exposure to sodium hydroxide that are effective with conventional microorganisms. However, in common with other TSE agents, the BSE agent appears to be effectively inactivated by exposure to sodium hypochlorite solutions containing high levels of available chlorine. Not surprisingly, the BSE agent has been found to survive at least some of the rendering processes that were used to process tissues discarded by abattoirs in the EU during the early 1980s. Despite the survival of BSE infectivity after autoclaving or exposure to sodium hydroxide, it is known that combining these procedures results in a very reliable degree of inactivation for TSE agents generally. The combination of heat and alkali has also been shown to be effective with a mouse-passaged strain of BSE agent, even at a temperature of only 100 degrees C for a minute. Also, in carrying out BSE-spiked validation studies relating to the safety of bone-derived gelatin, it has also been found that the exposure of acid-treated bone (which is free from any obvious remains of fatty or proteinaceous tissue) to 0.3 M sodium hydroxide for two hours knocks out any residual BSE infectivity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11862625     DOI: 10.1016/s1631-0691(02)01386-0

Source DB:  PubMed          Journal:  C R Biol        ISSN: 1631-0691            Impact factor:   1.583


  7 in total

1.  Use of freeze-dried bone allografts in revision total hip arthroplasty.

Authors:  Maurice Caltran; Claude Savornin; Patrick Le Couteur; Paul Jouan; Philippe Deroche; Jean-François Vinceneux; Laurence Barnouin
Journal:  Eur J Orthop Surg Traumatol       Date:  2002-12-17

2.  Treatment of Prion Disease with Heterologous Prion Proteins.

Authors:  Pamela J Skinner; Hyeon O Kim; Damani Bryant; Nikilyn J Kinzel; Cavan Reilly; Suzette A Priola; Anne E Ward; Patricia A Goodman; Katherine Olson; Davis M Seelig
Journal:  PLoS One       Date:  2015-07-02       Impact factor: 3.240

3.  Wide distribution of prion infectivity in the peripheral tissues of vCJD and sCJD patients.

Authors:  Jean-Yves Douet; Alvina Huor; Hervé Cassard; Séverine Lugan; Naima Aron; Mark Arnold; Didier Vilette; Juan-Maria Torres; James W Ironside; Olivier Andreoletti
Journal:  Acta Neuropathol       Date:  2021-02-02       Impact factor: 17.088

4.  In vitro and in vivo evaluation of lyophilized bovine bone biocompatibility.

Authors:  Carlos Roberto Galia; Carlos Alberto Macedo; Ricardo Rosito; Tielle Muller de Mello; Lourdes Maria Araújo Quaresma Camargo; Luis Fernando Moreira
Journal:  Clinics (Sao Paulo)       Date:  2008-12       Impact factor: 2.365

5.  Acetabular reconstruction with human and bovine freeze-dried bone grafts and a reinforcement device.

Authors:  Ricardo Rosito; Carlos Roberto Galia; Carlos Alberto Souza Macedo; Luis Fernando Moreira; Lourdes Maria Araújo C Quaresma; Humberto Moreira Palma
Journal:  Clinics (Sao Paulo)       Date:  2008-08       Impact factor: 2.365

6.  Distribution and Quantitative Estimates of Variant Creutzfeldt-Jakob Disease Prions in Tissues of Clinical and Asymptomatic Patients.

Authors:  Jean Y Douet; Caroline Lacroux; Naima Aron; Mark W Head; Séverine Lugan; Cécile Tillier; Alvina Huor; Hervé Cassard; Mark Arnold; Vincent Beringue; James W Ironside; Olivier Andréoletti
Journal:  Emerg Infect Dis       Date:  2017-06       Impact factor: 6.883

Review 7.  Reconstitution of GABA, Glycine and Glutamate Transporters.

Authors:  Niels Christian Danbolt; Beatriz López-Corcuera; Yun Zhou
Journal:  Neurochem Res       Date:  2021-04-27       Impact factor: 3.996

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.